Perfil
Mark L.
Levitt is currently Director at EnGeneIC Pty Ltd. and Chief Scientific Officer at RedHill Biopharma Ltd. since 2017.
Formerly, Dr. Levitt was Director at UPMC Cancer Institute and Head of the Lung Cancer Unit at Sheba Medical Center.
Cargos activos de Mark Levitt
| Empresas | Cargo | Inicio |
|---|---|---|
| REDHILL BIOPHARMA LTD. | Director Técnico/Científico/I+D | 01/01/2017 |
EnGeneIC Pty Ltd.
EnGeneIC Pty Ltd. BiotechnologyHealth Technology Develops and commercializes novel concepts for the targeted delivery of drugs and other therapeutic molecules used in the treatment of cancer | Director/Miembro de la Junta | - |
Antiguos cargos conocidos de Mark Levitt.
| Empresas | Cargo | Fin |
|---|---|---|
UPMC Cancer Institute
UPMC Cancer Institute Medical/Nursing ServicesHealth Services Provides health care and insurance services | Director/Miembro de la Junta | - |
Sheba Medical Center
Sheba Medical Center Hospital/Nursing ManagementHealth Services Operates as a hospital | Corporate Officer/Principal | - |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas privadas | 4 |
|---|---|
EnGeneIC Pty Ltd.
EnGeneIC Pty Ltd. BiotechnologyHealth Technology Develops and commercializes novel concepts for the targeted delivery of drugs and other therapeutic molecules used in the treatment of cancer | Health Technology |
Sheba Medical Center
Sheba Medical Center Hospital/Nursing ManagementHealth Services Operates as a hospital | Health Services |
UPMC Cancer Institute
UPMC Cancer Institute Medical/Nursing ServicesHealth Services Provides health care and insurance services | Health Services |
RedHill Biopharma Ltd.
RedHill Biopharma Ltd. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that provides GI, infectious diseases, medical countermeasures and oncology services | Health Technology |
- Bolsa de valores
- Insiders
- Mark Levitt
















